featured
ASH 2018: Shorter Course of CHOP + Rituximab Noninferior to Standard of Care in Younger Patients With DLBCL
A shorter course of chemotherapy means fewer adverse events and a more rapid return to normal activities
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.